Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

NCT06189170 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety Issues
Tolerance

Interventions

DRUG: KP405
DRUG: Placebo

Sponsor

Kariya Pharmaceuticals